Elsevier Science Ltd.

SHERPA: Unknown

People

  1. Boelens
    Boelens
  2. O'Reilly
    O'Reilly
  3. Curran
    Curran
  4. Mcavoy
    Mcavoy
  5. Cancio
    Cancio
  6. Oved
    Oved
  7. Mauguen
    Mauguen
  8. Scaradavou
    Scaradavou
  9. Troullioud Lucas
    Troullioud Lucas
  10. Maryamchik
    Maryamchik

Groups

  1. Pediatrics, Department of (43)
  2. Stem Cell Transplantation and Cellular Therapy Service (43)
  3. Tow Center for Developmental Oncology (TCDO) (41)
  4. Department of Medicine (38)
  5. GSK Faculty (24)
  6. Center for Hematologic Malignancies (22)
  7. Hematologic Malignancies, Division of (22)
  8. Sloan Kettering Institute Faculty (20)
  9. Immunology Program Faculty (16)
  10. Adult Leukemia (11)
Search Within
Formats
  1. Meeting Abstract (34)
  2. Journal Article (28)
  3. Review (8)
  4. Guidelines (3)
  5. Book Section (1)
Groups
  1. Pediatrics, Department of (43)
  2. Stem Cell Transplantation and Cellular Therapy Service (43)
  3. Tow Center for Developmental Oncology (TCDO) (41)
  4. Department of Medicine (38)
  5. GSK Faculty (24)
  6. Center for Hematologic Malignancies (22)

More Groups

People
  1. Jaap Jan Boelens (34)
  2. Richard O'Reilly (12)
  3. Susan Prockop (10)
  4. Devin Mcavoy (9)
  5. Elizabeth Klein (9)
  6. Kevin Curran (9)

More People

Years
  1. 2025 (9)
  2. 2024 (8)
  3. 2023 (6)
  4. 2022 (10)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Cytotherapy (73)
  2. Encyclopedia of Creativity. 3rd ed (1)

Results (74)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A machine learning model that incorporates CD45 mean fluorescence intensity (MFI) and cell composition predicts poor viability of hematopoietic progenitor cells after freeze-thaw
    Meeting Abstract

    Al-Riyami, A. Z.; Kadauke, S.; Hanna, R. S.; Azar, A. P.; Maryamchik, E.; Zheng, X.; Zhang, X.; Finn, C.; Giacobbe, N.; Rieser, R.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: The importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes
    Guidelines

    Bertaina, A.; Abraham, A.; Bonfim, C.; Cohen, S.; Purtill, D.; Ruggeri, A.; Weiss, D.; Wynn, R.; Boelens, J. J.; Prockop, S.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Curative therapy for hemoglobinopathies: An International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation
    Review

    Leonard, A.; Bertaina, A.; Bonfim, C.; Cohen, S.; Prockop, S.; Purtill, D.; Russell, A.; Boelens, J. J.; Wynn, R.; Ruggeri, A.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Options for imaging cellular therapeutics in vivo: A multi-stakeholder perspective
    Review

    Helfer, B. M.; Ponomarev, V.; Patrick, P. S.; Blower, P. J.; Feitel, A.; Fruhwirth, G. O.; Jackman, S.; Pereira Mouriè€s, L.; Park, M. V. D. Z.; Srinivas, M.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Impact of Fanconi anemia genotype on outcome after hematopoietic stem cell transplant: A single centre experience of 20 years
    Meeting Abstract

    Jain, S.; Mauguen, A.; Djavid, A. R.; Kennedy, J. A.; Smogorzewska, A.; Walsh, M.; Boelens, J. J.; Cancio, M.
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium
    Meeting Abstract

    Curran, K. J.; Fabrizio, V. A.; Mauguen, A.; Boelens, J. J.; Baggott, C.; Prabhu, S.; Placenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Emerging trends in COVID-19 treatment: Learning from inflammatory conditions associated with cellular therapies
    Review

    Cancio, M.; Ciccocioppo, R.; Rocco, P. R. M.; Levine, B. L.; Bronte, V.; Bollard, C. M.; Weiss, D.; Boelens, J. J.; Hanley, P. J.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
    Journal Article

    van Roessel, I.; Prockop, S.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; O'Reilly, R. J.; Kernan, N. A.; more...
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells
    Meeting Abstract

    Wang, X.; Zabierowski, S.; Wu, M.; Del Casale, C.; Eyquem, J.; Mansilla-Soto, J.; Riviere, I.; Sadelain, M.
    Cytotherapy (2020)

    Fulltext@MSK | Save

    • Elsevier Science Ltd. – authorized name for: